Teva Pharmaceutical Industries reported $1.14B in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aerie Pharmaceuticals AERI:US $ -29.84M 2.88M
Amarin AMRN:US $ 9.56M 10.38M
Amgen AMGN:US $ 3188M 218M
Antares Pharma ATRS:US $ 7.71M 1.42M
AstraZeneca AZN:LN 2149M 322M
Biogen BIIB:US $ 1147.6M 41.7M
Bristol Myers Squibb BMY:US $ 5679M 455M
Coherus Biosciences CHRS:US $ -23.29M 143.22M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Emergent Biosolutions EBS:US $ 47.7M 76.4M
Endo International Ordinary Shares ENDP:US $ 314.75M 18.87M
Flexion Therapeutics FLXN:US $ -16357000 6.26M
Gilead Sciences GILD:US $ 2816M 669M
GlaxoSmithKline GSK:LN 2626M 584M
Henry Schein HSIC:US $ 260.86M 21.36M
Horizon Pharma HZNP:US $ 305.69M 324.32M
JAZZ PHA JAZZ:US $ 77.72M 157.36M
Lannett LCI:US $ 4.57M 7.98M
Novartis NOVN:VX SF 4772M 423M
Pacira Pharmaceuticals PCRX:US $ 39.89M 13.68M
Patterson Companies PDCO:US $ 68.56M 10.68M
Perrigo Ordinary Shares PRGO:US $ 119M 18.5M
Pfizer PFE:US $ 7593M 610M
Phibro Animal Health PAHC:US $ 27M 1.05M
Revance Therapeutics RVNC:US $ -65.29M 0.48M
Sun Pharmaceuticals SUNP:IN IR 27412M 6819.8M
Supernus Pharmaceuticals SUPN:US $ 40.06M 20.24M
Teva Pharmaceutical Industries TEVA:US $ 1136M 34M
Xeris Pharmaceuticals Inc XERS:US $ -25467000 9.06M
Zoetis ZTS:US $ 838M 30M